![Michael Williams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Williams
Directeur/Membre du Conseil chez
Sarcio, Inc.
Profil
Michael Williams is currently a Board Member at Sarcio, Inc. and a Partner at PACE Healthcare Capital.
Previously, he served as a Non-Executive Director at PYC Therapeutics Ltd. in 2018 and as a Vice President at Bristol Myers Squibb Co. from 2004 to 2005.
He also held positions at Pfizer Inc. as a Vice President and at Intarcia Therapeutics, Inc. as a Chief Operating Officer.
Mr. Williams obtained his undergraduate degree from the University Of Bangor and his graduate degree in 1982 from the same institution.
Postes actifs de Michael Williams
| Sociétés | Poste | Début |
|---|---|---|
PACE Healthcare Capital
 PACE Healthcare Capital Investment ManagersFinance PACE Healthcare invests in companies located in the United States. The firm focuses on digital healthcare and healthcare technology sectors. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.25 - 2 million. | Consultant / Advisor | - |
Sarcio, Inc.
 Sarcio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing an off the shelf, injectable, regenerative therapy to delay or prevent the need for joint replacement | Directeur/Membre du Conseil | 01/07/2021 |
Anciens postes connus de Michael Williams
| Sociétés | Poste | Fin |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Directeur/Membre du Conseil | 11/04/2018 |
| BRISTOL-MYERS SQUIBB COMPANY | Private Equity Investor | 01/01/2005 |
| PFIZER INC. | Private Equity Investor | - |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Directeur des opérations | - |
Formation de Michael Williams
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
35
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
PYC Therapeutics Ltd.
 PYC Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides discovery and development of peptide based therapeutic candidates | Health Technology |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
University Of Bangor
 University Of Bangor Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sarcio, Inc.
Sarcio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing an off the shelf, injectable, regenerative therapy to delay or prevent the need for joint replacement | Commercial Services |
PACE Healthcare Capital
PACE Healthcare Capital Investment ManagersFinance PACE Healthcare invests in companies located in the United States. The firm focuses on digital healthcare and healthcare technology sectors. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.25 - 2 million. | Finance |
